All posts by: Michael Zand

About Michael Zand

Practicality of CAR T Therapy – OncLive

Continue reading

2018-01-11 NEWS

OncLive

Practicality of CAR T Therapy
OncLive
Stephen J. Schuster, MD: I think, currently, the products can be prepared within 17 to 22 days, depending on which CAR you’re talking about. And that seems like a relatively short period of time but in a very sick patient who has a rapidly progressing

Continue reading

2018-01-11 NEWS

OncLive

Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer
OncLive
Mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) testing may improve classifications of endometrial cancer and lead to personalized treatment options, according to Martee L. Hensley, MD. If patients’ tumors test positive

Continue reading

2018-01-11 NEWS

OncLive

Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer
OncLive
Mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) testing may improve classifications of endometrial cancer and lead to personalized treatment options, according to Martee L. Hensley, MD. If patients’ tumors test positive